Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,816,745
+$10,625,789 QoQ
Shares Held
42,985
+4795.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#888
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFG Advisory, LLC holds $39,371,083 across 16 Drug Manufacturers - General names. ABBV ranks #1 (27.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
42,985 | $10,816,745 | |
| 2 | JNJ |
Johnson & Johnson
|
39,578 | $10,051,624 | |
| 3 | LLY |
ELI LILLY & Co
|
4,333 | $5,197,130 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
64,156 | $3,696,668 | |
| 5 | AMGN |
Amgen Inc
|
9,053 | $3,278,272 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,458 | $2,628,853 | |
| 7 | PFE |
Pfizer Inc
|
39,164 | $943,069 | |
| 8 | GSK |
GSK plc
|
16,758 | $878,454 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,816,745 | 42,985 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $190,956 | 878 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,341,813 | 40,885 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,544,541 | 41,222 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,369,299 | 39,701 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $8,046,406 | 38,404 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,668,014 | 37,524 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,420,903 | 37,578 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $6,379,686 | 37,195 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $6,590,927 | 36,194 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,781,465 | 37,307 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $3,619,922 | 24,285 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,178,550 | 23,592 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,908,708 | 24,526 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $3,626,851 | 22,442 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,822,837 | 28,484 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $3,262,001 | 21,298 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,060,369 | 25,047 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,567,113 | 26,345 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,578,093 | 23,900 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,627,778 | 23,329 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $2,903,759 | 26,832 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,844,082 | 26,543 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,075,460 | 35,112 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $3,337,236 | 33,991 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,258,881 | 29,648 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||